Free Trial

Revvity RVTY (Baa3/BBB stable): 1Q24 Results

HEALTHCARE

Revvity (Perkin Elmer) came in slightly ahead of consensus. Organic revenue growth was -3% which was fairly lack-lustre.


• Adj. Operating Income $165.8m (+3% beat).

• Revenue $650m in-line• Revvity only has one EUR bond RVTY 1.875 26. The company has not issued since 2021 and has a $800m bond maturing in Sep-24. They mainly issue in $.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.